Bobulsky Susan: insider trades.
Bobulsky Susan reported 5 non-derivative transactions on 5 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($264K), across 1 company.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 5
- Companies
- 1
- Name as filed
- BOBULSKY SUSAN
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | Officer · Chief Commercial Officer, MRD | 5 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-15 | Adaptive Biotechnologies Corp | S | 1,195 | $27 | 395,794 | Form 4 |
| 2026-08-10 | Adaptive Biotechnologies Corp | S | 3,000 | $25 | 396,989 | Form 4 |
| 2026-07-30 | Adaptive Biotechnologies Corp | S | 1,299 | $24 | 399,989 | Form 4 |
| 2026-07-16 | Adaptive Biotechnologies Corp | S | 5,000 | $23 | 401,288 | Form 4 |
| 2026-07-01 | Adaptive Biotechnologies Corp | S | 487 | $22 | 406,288 | Form 4 |
Questions
What stock did Bobulsky Susan buy or sell?
Bobulsky Susan reported 5 non-derivative transactions on 5 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($264K), across 1 company.
Is Bobulsky Susan the same person as other filers with this name?
This page covers SEC CIK 1820885 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/bobulsky-susan-1820885.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.